Compounds for inflammation and immune-related uses

Details for Australian Patent Application No. 2004259024 (hide)

Owner Synta Pharmaceuticals, Corp.

Inventors Mahiou, Jerome; Sun, Lijun; Yu, ChihYi; Chen, Shoujun; Xie, Yu; Chimmanamada, Dinesh; Ono, Mitsunori; Holmqvist, Mats; Jiang, Jun; Zhang, Shijie

Agent Shelston IP

Pub. Number AU-B-2004259024

PCT Pub. Number WO2005/009539

Priority 60/489,711 23.07.03 US

Filing date 22 July 2004

Wipo publication date 3 February 2005

Acceptance publication date 23 June 2011

International Classifications

A61P 27/00 (2006.01) Drugs for disorders of the senses

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Event Publications

23 February 2006 PCT application entered the National Phase

  PCT publication WO2005/009539 Priority application(s): WO2005/009539

23 June 2011 Application Accepted

  Published as AU-B-2004259024

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259027-Tissue adhesive sealant

2004259019-Acellular tissue matrices made from galactose alpha-1,3-galactose-deficient tissue